A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Identifier
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Statistics in medicine. 40. 26. 2021. 5702. 5724. -
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wer)
-
Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
- (wann)
-
2021
- Urheber
-
Toenges, Gerrit
Mütze, Tobias
Jahn-Eimermacher, Antje
- DOI
-
10.25358/openscience-7703
- Handle
- URN
-
urn:nbn:de:101:1-2022090802400057347632
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Toenges, Gerrit
- Mütze, Tobias
- Jahn-Eimermacher, Antje
- Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
Entstanden
- 2021
Ähnliche Objekte (12)
Methods for planning and analyzing clinical trials with composite endpoints
Improving the analysis of composite endpoints in rare disease trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Surrogate endpoints in trials: a call for better reporting
Endpoints in stem cell trials in ischemic heart failure
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Methods for planning and analyzing clinical trials with composite endpoints
Improving the analysis of composite endpoints in rare disease trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Surrogate endpoints in trials: a call for better reporting
Endpoints in stem cell trials in ischemic heart failure
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Methods for planning and analyzing clinical trials with composite endpoints
Improving the analysis of composite endpoints in rare disease trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Surrogate endpoints in trials: a call for better reporting
Endpoints in stem cell trials in ischemic heart failure